Document is current

Any future updates will be listed below

Extensive toxic epidermal necrolysis following brentuximab vedotin administration

Crossref DOI link: https://doi.org/10.1007/s00277-014-2148-3

Published Online: 2014-07-02

Published Print: 2015-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark